Tag: manta

Teleflex acquires Essential Medical

Teleflex Incorporated has announced that it has acquired Essential Medical, a privately-held medical device company that has developed and commercialised the CE Marked Manta...

TVT 2018: Positive results for Manta large bore closure device

Results from the SAFE MANTA IDE clinical trial—the first pivotal trial for a dedicated large bore closure device (Manta, Essential Medical)—show haemostasis was achieved...

Manta large bore vascular closure device to be evaluated in 500-patient...

Essential Medical has announced initiation of enrolment in a post-market clinical registry in the regions where Manta is commercially available. Principal investigator Nicolas Van Mieghem,...

Essential Medical completes enrolment in US IDE trial of Manta

Essential Medical has announced the completion of enrolment in the US pivotal investigational device exemption (IDE) trial of the Manta large bore vascular closure...

Essential Medical marks first 1,000 Manta cases and expands production capacity

Essential Medical has announced that more than 1,000 Manta large bore vascular closure devices have been successfully deployed globally. To meet the growing demands...

Essential Medical addressing the growing large bore vascular closure market

Essential Medical has announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous plug-based arteriotomy closure device for large-bore...

US trial of Essential Medical’s MANTA device begins

Essential Medical has announced the start of the Manta vascular closure device US pivotal trial. The first US case was performed on November 28 by...

Essential Medical announces closing on US$14.9 million series B funding

Essential Medical has announced that it has completed a series B financing of US$14.9 million. The round was led by Amzak Health along with...

Essential Medical announces FDA approval to begin US trial for the...

Essential Medical announced on 8 July 2016 that it has received investigational device exemption (IDE) approval from the FDA to begin the US clinical...